BindingDB logo
myBDB logout

Patent code US10781171

Compile Data Set for Download or QSAR

Found 288 hits of Enzyme Inhibition Constant Data   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kJ/mole
IC50
nM
Kd
nM
EC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Free fatty acid receptor 2


(Homo sapiens (Human))
BDBM404211
PNG
((2S,5R)-5-(2-cyanophenyl)-1-(2'-methoxy-[1,1'-biph...)
Show SMILES OC(=O)[C@@H]1CC[C@@H](N1C(=O)C1CCN(CC1)c1ccc(cc1[N+]([O-])=O)C(F)(F)F)c1ccccc1Cl
Show InChI InChI=1S/C24H23ClF3N3O5/c25-17-4-2-1-3-16(17)18-7-8-20(23(33)34)30(18)22(32)14-9-11-29(12-10-14)19-6-5-15(24(26,27)28)13-21(19)31(35)36/h1-6,13-14,18,20H,7-12H2,(H,33,34)/t18-,20+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
<1.00E+3n/an/an/an/an/an/an/an/a



Epics Therapeutics

US Patent


Assay Description
Human GPR43 radioligand binding assay is performed by adding successively in the wells of a 96 well plate (Master Block, Greiner, 786201), 50 ul of c...


US Patent US10781171 (2020)

More data for this
Ligand-Target Pair
Free fatty acid receptor 2


(Homo sapiens (Human))
BDBM408766
PNG
((2S,5R)-1-(1-(5-chloro-2-nitrophenyl)piperidine-4-...)
Show SMILES OC(=O)[C@@H]1CC[C@@H](N1C(=O)C1CCN(CC1)c1cc(Cl)ccc1[N+]([O-])=O)c1ccccc1Cl
Show InChI InChI=1S/C23H23Cl2N3O5/c24-15-5-6-19(28(32)33)21(13-15)26-11-9-14(10-12-26)22(29)27-18(7-8-20(27)23(30)31)16-3-1-2-4-17(16)25/h1-6,13-14,18,20H,7-12H2,(H,30,31)/t18-,20+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
<1.00E+3n/an/an/an/an/an/an/an/a



Epics Therapeutics

US Patent


Assay Description
Human GPR43 radioligand binding assay is performed by adding successively in the wells of a 96 well plate (Master Block, Greiner, 786201), 50 ul of c...


US Patent US10781171 (2020)

More data for this
Ligand-Target Pair
Free fatty acid receptor 2


(Homo sapiens (Human))
BDBM408761
PNG
((2S,5R)-5-(2-chlorophenyl)-1-(1-(4-methyl-2-nitrop...)
Show SMILES Cc1ccc(N2CCC(CC2)C(=O)N2[C@@H](CC[C@@H]2c2ccccc2Cl)C(O)=O)c(c1)[N+]([O-])=O
Show InChI InChI=1S/C24H26ClN3O5/c1-15-6-7-20(22(14-15)28(32)33)26-12-10-16(11-13-26)23(29)27-19(8-9-21(27)24(30)31)17-4-2-3-5-18(17)25/h2-7,14,16,19,21H,8-13H2,1H3,(H,30,31)/t19-,21+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
1.50E+3n/an/an/an/an/an/an/an/a



Epics Therapeutics

US Patent


Assay Description
Human GPR43 radioligand binding assay is performed by adding successively in the wells of a 96 well plate (Master Block, Greiner, 786201), 50 ul of c...


US Patent US10781171 (2020)

More data for this
Ligand-Target Pair
Free fatty acid receptor 2


(Homo sapiens (Human))
BDBM408762
PNG
((2S,5R)-5-(2-chlorophenyl)-1-(1-(2-cyano-4-nitroph...)
Show SMILES OC(=O)[C@@H]1CC[C@@H](N1C(=O)C1CCN(CC1)c1ccc(cc1C#N)[N+]([O-])=O)c1ccccc1Cl
Show InChI InChI=1S/C24H23ClN4O5/c25-19-4-2-1-3-18(19)21-7-8-22(24(31)32)28(21)23(30)15-9-11-27(12-10-15)20-6-5-17(29(33)34)13-16(20)14-26/h1-6,13,15,21-22H,7-12H2,(H,31,32)/t21-,22+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
1.50E+3n/an/an/an/an/an/an/an/a



Epics Therapeutics

US Patent


Assay Description
Human GPR43 radioligand binding assay is performed by adding successively in the wells of a 96 well plate (Master Block, Greiner, 786201), 50 ul of c...


US Patent US10781171 (2020)

More data for this
Ligand-Target Pair
Free fatty acid receptor 2


(Homo sapiens (Human))
BDBM404212
PNG
((2S,5R)-5-(2-chlorophenyl)-1-(2'-cyano-4'-methoxy-...)
Show SMILES OC(=O)[C@@H]1CC[C@@H](N1C(=O)C1CCN(CC1)c1ccc(cc1[N+]([O-])=O)S(=O)(=O)N1CCCCC1)c1ccccc1Cl
Show InChI InChI=1S/C28H33ClN4O7S/c29-22-7-3-2-6-21(22)23-10-11-25(28(35)36)32(23)27(34)19-12-16-30(17-13-19)24-9-8-20(18-26(24)33(37)38)41(39,40)31-14-4-1-5-15-31/h2-3,6-9,18-19,23,25H,1,4-5,10-17H2,(H,35,36)/t23-,25+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
1.50E+3n/an/an/an/an/an/an/an/a



Epics Therapeutics

US Patent


Assay Description
Human GPR43 radioligand binding assay is performed by adding successively in the wells of a 96 well plate (Master Block, Greiner, 786201), 50 ul of c...


US Patent US10781171 (2020)

More data for this
Ligand-Target Pair
Free fatty acid receptor 2


(Homo sapiens (Human))
BDBM408765
PNG
( (2S,5R)-5-(2-chlorophenyl)-1-(1-(3-methoxy-4-nitr...)
Show SMILES COc1cc(ccc1[N+]([O-])=O)N1CCC(CC1)C(=O)N1[C@@H](CC[C@@H]1c1ccccc1Cl)C(O)=O
Show InChI InChI=1S/C24H26ClN3O6/c1-34-22-14-16(6-7-20(22)28(32)33)26-12-10-15(11-13-26)23(29)27-19(8-9-21(27)24(30)31)17-4-2-3-5-18(17)25/h2-7,14-15,19,21H,8-13H2,1H3,(H,30,31)/t19-,21+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
>2.00E+3n/an/an/an/an/an/an/an/a



Epics Therapeutics

US Patent


Assay Description
Human GPR43 radioligand binding assay is performed by adding successively in the wells of a 96 well plate (Master Block, Greiner, 786201), 50 ul of c...


US Patent US10781171 (2020)

More data for this
Ligand-Target Pair
Free fatty acid receptor 2


(Homo sapiens (Human))
BDBM408758
PNG
( (2S,5R)-5-(2-chlorophenyl)-1-(1-(4-(morpholinosul...)
Show SMILES OC(=O)[C@@H]1CC[C@@H](N1C(=O)C1CCN(CC1)c1ccc(cc1[N+]([O-])=O)S(=O)(=O)N1CCOCC1)c1ccccc1Cl
Show InChI InChI=1S/C27H31ClN4O8S/c28-21-4-2-1-3-20(21)22-7-8-24(27(34)35)31(22)26(33)18-9-11-29(12-10-18)23-6-5-19(17-25(23)32(36)37)41(38,39)30-13-15-40-16-14-30/h1-6,17-18,22,24H,7-16H2,(H,34,35)/t22-,24+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
>2.00E+3n/an/an/an/an/an/an/an/a



Epics Therapeutics

US Patent


Assay Description
Human GPR43 radioligand binding assay is performed by adding successively in the wells of a 96 well plate (Master Block, Greiner, 786201), 50 ul of c...


US Patent US10781171 (2020)

More data for this
Ligand-Target Pair
Free fatty acid receptor 2


(Homo sapiens (Human))
BDBM408763
PNG
( (2S,5R)-5-(2-chlorophenyl)-1-(1-(4-nitrophenyl)pi...)
Show SMILES OC(=O)[C@@H]1CC[C@@H](N1C(=O)C1CCN(CC1)c1ccc(cc1)[N+]([O-])=O)c1ccccc1Cl
Show InChI InChI=1S/C23H24ClN3O5/c24-19-4-2-1-3-18(19)20-9-10-21(23(29)30)26(20)22(28)15-11-13-25(14-12-15)16-5-7-17(8-6-16)27(31)32/h1-8,15,20-21H,9-14H2,(H,29,30)/t20-,21+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
>2.00E+3n/an/an/an/an/an/an/an/a



Epics Therapeutics

US Patent


Assay Description
Human GPR43 radioligand binding assay is performed by adding successively in the wells of a 96 well plate (Master Block, Greiner, 786201), 50 ul of c...


US Patent US10781171 (2020)

More data for this
Ligand-Target Pair
Free fatty acid receptor 2


(Homo sapiens (Human))
BDBM408764
PNG
((2S,5R)-5-(2-chlorophenyl)-1-(1-(2-fluoro-4-nitrop...)
Show SMILES OC(=O)[C@@H]1CC[C@@H](N1C(=O)C1CCN(CC1)c1ccc(cc1F)[N+]([O-])=O)c1ccccc1Cl
Show InChI InChI=1S/C23H23ClFN3O5/c24-17-4-2-1-3-16(17)19-7-8-21(23(30)31)27(19)22(29)14-9-11-26(12-10-14)20-6-5-15(28(32)33)13-18(20)25/h1-6,13-14,19,21H,7-12H2,(H,30,31)/t19-,21+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
>2.00E+3n/an/an/an/an/an/an/an/a



Epics Therapeutics

US Patent


Assay Description
Human GPR43 radioligand binding assay is performed by adding successively in the wells of a 96 well plate (Master Block, Greiner, 786201), 50 ul of c...


US Patent US10781171 (2020)

More data for this
Ligand-Target Pair
Free fatty acid receptor 2


(Homo sapiens (Human))
BDBM408760
PNG
((2S,5R)-5-(2-chlorophenyl)-1-(1-(4-(N,N-diethylsul...)
Show SMILES CCN(CC)S(=O)(=O)c1ccc(N2CCC(CC2)C(=O)N2[C@@H](CC[C@@H]2c2ccccc2Cl)C(O)=O)c(c1)[N+]([O-])=O
Show InChI InChI=1S/C27H33ClN4O7S/c1-3-30(4-2)40(38,39)19-9-10-23(25(17-19)32(36)37)29-15-13-18(14-16-29)26(33)31-22(11-12-24(31)27(34)35)20-7-5-6-8-21(20)28/h5-10,17-18,22,24H,3-4,11-16H2,1-2H3,(H,34,35)/t22-,24+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
>2.00E+3n/an/an/an/an/an/an/an/a



Epics Therapeutics

US Patent


Assay Description
Human GPR43 radioligand binding assay is performed by adding successively in the wells of a 96 well plate (Master Block, Greiner, 786201), 50 ul of c...


US Patent US10781171 (2020)

More data for this
Ligand-Target Pair
Free fatty acid receptor 2


(Homo sapiens (Human))
BDBM408767
PNG
((2S,5R)-5-(2-chlorophenyl)-1-(1-(2-nitrophenyl)pip...)
Show SMILES OC(=O)[C@@H]1CC[C@@H](N1C(=O)C1CCN(CC1)c1ccccc1[N+]([O-])=O)c1ccccc1Cl
Show InChI InChI=1S/C23H24ClN3O5/c24-17-6-2-1-5-16(17)18-9-10-21(23(29)30)26(18)22(28)15-11-13-25(14-12-15)19-7-3-4-8-20(19)27(31)32/h1-8,15,18,21H,9-14H2,(H,29,30)/t18-,21+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
>2.00E+3n/an/an/an/an/an/an/an/a



Epics Therapeutics

US Patent


Assay Description
Human GPR43 radioligand binding assay is performed by adding successively in the wells of a 96 well plate (Master Block, Greiner, 786201), 50 ul of c...


US Patent US10781171 (2020)

More data for this
Ligand-Target Pair
Free fatty acid receptor 2


(Homo sapiens (Human))
BDBM403787
PNG
((2S,5R)-1-([1,1'-biphenyl]-4-carbonyl)-5-(2-chloro...)
Show SMILES OC(=O)[C@@H]1CC[C@@H](N1C(=O)c1ccc(cc1)-c1ccccc1)c1ccccc1Cl
Show InChI InChI=1S/C24H20ClNO3/c25-20-9-5-4-8-19(20)21-14-15-22(24(28)29)26(21)23(27)18-12-10-17(11-13-18)16-6-2-1-3-7-16/h1-13,21-22H,14-15H2,(H,28,29)/t21-,22+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 600n/an/an/an/a



Epics Therapeutics

US Patent


Assay Description
The assay was used to determine the activity of the compounds of the invention.The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM N...


US Patent US10781171 (2020)

More data for this
Ligand-Target Pair
Free fatty acid receptor 2


(Homo sapiens (Human))
BDBM403792
PNG
((2S,5R)-5-(2-chlorophenyl)-1-(3'-methoxy-[1,1'-bip...)
Show SMILES COc1cccc(c1)-c1ccc(cc1)C(=O)N1[C@@H](CC[C@@H]1c1ccccc1Cl)C(O)=O
Show InChI InChI=1S/C25H22ClNO4/c1-31-19-6-4-5-18(15-19)16-9-11-17(12-10-16)24(28)27-22(13-14-23(27)25(29)30)20-7-2-3-8-21(20)26/h2-12,15,22-23H,13-14H2,1H3,(H,29,30)/t22-,23+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 600n/an/an/an/a



Epics Therapeutics

US Patent


Assay Description
The assay was used to determine the activity of the compounds of the invention.The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM N...


US Patent US10781171 (2020)

More data for this
Ligand-Target Pair
Free fatty acid receptor 2


(Homo sapiens (Human))
BDBM403795
PNG
((2S,5R)-5-(2-chlorophenyl)-1-(4-((2-fluorobenzyl)o...)
Show SMILES OC(=O)[C@@H]1CC[C@@H](N1C(=O)c1ccc(OCc2ccccc2F)cc1)c1ccccc1Cl
Show InChI InChI=1S/C25H21ClFNO4/c26-20-7-3-2-6-19(20)22-13-14-23(25(30)31)28(22)24(29)16-9-11-18(12-10-16)32-15-17-5-1-4-8-21(17)27/h1-12,22-23H,13-15H2,(H,30,31)/t22-,23+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 600n/an/an/an/a



Epics Therapeutics

US Patent


Assay Description
The assay was used to determine the activity of the compounds of the invention.The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM N...


US Patent US10781171 (2020)

More data for this
Ligand-Target Pair
Free fatty acid receptor 2


(Homo sapiens (Human))
BDBM403800
PNG
((2S,5R)-5-(2-chlorophenyl)-1-(3,5-diethoxybenzoyl)...)
Show SMILES CCOc1cc(OCC)cc(c1)C(=O)N1[C@@H](CC[C@@H]1c1ccccc1Cl)C(O)=O
Show InChI InChI=1S/C22H24ClNO5/c1-3-28-15-11-14(12-16(13-15)29-4-2)21(25)24-19(9-10-20(24)22(26)27)17-7-5-6-8-18(17)23/h5-8,11-13,19-20H,3-4,9-10H2,1-2H3,(H,26,27)/t19-,20+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 600n/an/an/an/a



Epics Therapeutics

US Patent


Assay Description
The assay was used to determine the activity of the compounds of the invention.The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM N...


US Patent US10781171 (2020)

More data for this
Ligand-Target Pair
Free fatty acid receptor 2


(Homo sapiens (Human))
BDBM403814
PNG
((2S,5R)-5-(2-chlorophenyl)-1-(3-methoxybenzoyl)pyr...)
Show SMILES COc1cccc(c1)C(=O)N1[C@@H](CC[C@@H]1c1ccccc1Cl)C(O)=O
Show InChI InChI=1S/C19H18ClNO4/c1-25-13-6-4-5-12(11-13)18(22)21-16(9-10-17(21)19(23)24)14-7-2-3-8-15(14)20/h2-8,11,16-17H,9-10H2,1H3,(H,23,24)/t16-,17+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a>1.00E+3n/an/an/an/a



Epics Therapeutics

US Patent


Assay Description
The assay was used to determine the activity of the compounds of the invention.The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM N...


US Patent US10781171 (2020)

More data for this
Ligand-Target Pair
Free fatty acid receptor 2


(Homo sapiens (Human))
BDBM403829
PNG
((2S,5S)-5-(2-chlorophenyl)-1-(2'-methoxy-[1,1'-bip...)
Show SMILES COc1ccccc1-c1ccc(cc1)C(=O)N1[C@@H](CC[C@H]1c1ccccc1Cl)C(O)=O
Show InChI InChI=1S/C25H22ClNO4/c1-31-23-9-5-3-6-18(23)16-10-12-17(13-11-16)24(28)27-21(14-15-22(27)25(29)30)19-7-2-4-8-20(19)26/h2-13,21-22H,14-15H2,1H3,(H,29,30)/t21-,22-/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a>1.00E+3n/an/an/an/a



Epics Therapeutics

US Patent


Assay Description
The assay was used to determine the activity of the compounds of the invention.The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM N...


US Patent US10781171 (2020)

More data for this
Ligand-Target Pair
Free fatty acid receptor 2


(Homo sapiens (Human))
BDBM403832
PNG
((2R,5S)-1-([1,1'-biphenyl]-4-carbonyl)-5-phenylpyr...)
Show SMILES OC(=O)[C@H]1CC[C@H](N1C(=O)c1ccc(cc1)-c1ccccc1)c1ccccc1
Show InChI InChI=1S/C24H21NO3/c26-23(20-13-11-18(12-14-20)17-7-3-1-4-8-17)25-21(15-16-22(25)24(27)28)19-9-5-2-6-10-19/h1-14,21-22H,15-16H2,(H,27,28)/t21-,22+/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a>1.00E+3n/an/an/an/a



Epics Therapeutics

US Patent


Assay Description
The assay was used to determine the activity of the compounds of the invention.The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM N...


US Patent US10781171 (2020)

More data for this
Ligand-Target Pair
Free fatty acid receptor 2


(Homo sapiens (Human))
BDBM403836
PNG
((2S,5R)-5-(2-chlorophenyl)-1-(2-(2-chlorophenyl)py...)
Show SMILES OC(=O)[C@@H]1CC[C@@H](N1C(=O)c1cnc(nc1)-c1ccccc1Cl)c1ccccc1Cl
Show InChI InChI=1S/C22H17Cl2N3O3/c23-16-7-3-1-5-14(16)18-9-10-19(22(29)30)27(18)21(28)13-11-25-20(26-12-13)15-6-2-4-8-17(15)24/h1-8,11-12,18-19H,9-10H2,(H,29,30)/t18-,19+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a>1.00E+3n/an/an/an/a



Epics Therapeutics

US Patent


Assay Description
The assay was used to determine the activity of the compounds of the invention.The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM N...


US Patent US10781171 (2020)

More data for this
Ligand-Target Pair
Free fatty acid receptor 2


(Homo sapiens (Human))
BDBM403854
PNG
((2S,5R)-5-(2-chlorophenyl)-1-(4-(pyrimidin-5-yl)be...)
Show SMILES OC(=O)[C@@H]1CC[C@@H](N1C(=O)c1ccc(cc1)-c1cncnc1)c1ccccc1Cl
Show InChI InChI=1S/C22H18ClN3O3/c23-18-4-2-1-3-17(18)19-9-10-20(22(28)29)26(19)21(27)15-7-5-14(6-8-15)16-11-24-13-25-12-16/h1-8,11-13,19-20H,9-10H2,(H,28,29)/t19-,20+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a>1.00E+3n/an/an/an/a



Epics Therapeutics

US Patent


Assay Description
The assay was used to determine the activity of the compounds of the invention.The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM N...


US Patent US10781171 (2020)

More data for this
Ligand-Target Pair
Free fatty acid receptor 2


(Homo sapiens (Human))
BDBM403879
PNG
((2S,5R)-5-(2-chlorophenyl)-1-(3'-(methylsulfonamid...)
Show SMILES CS(=O)(=O)Nc1cccc(c1)-c1ccc(cc1)C(=O)N1[C@@H](CC[C@@H]1c1ccccc1Cl)C(O)=O
Show InChI InChI=1S/C25H23ClN2O5S/c1-34(32,33)27-19-6-4-5-18(15-19)16-9-11-17(12-10-16)24(29)28-22(13-14-23(28)25(30)31)20-7-2-3-8-21(20)26/h2-12,15,22-23,27H,13-14H2,1H3,(H,30,31)/t22-,23+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a<200n/an/an/an/a



Epics Therapeutics

US Patent


Assay Description
The assay was used to determine the activity of the compounds of the invention.The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM N...


US Patent US10781171 (2020)

More data for this
Ligand-Target Pair
Free fatty acid receptor 2


(Homo sapiens (Human))
BDBM403880
PNG
((2S,5R)-5-(2-chlorophenyl)-1-(2'-(methylsulfonamid...)
Show SMILES CS(=O)(=O)Nc1ccccc1-c1ccc(cc1)C(=O)N1[C@@H](CC[C@@H]1c1ccccc1Cl)C(O)=O
Show InChI InChI=1S/C25H23ClN2O5S/c1-34(32,33)27-21-9-5-3-6-18(21)16-10-12-17(13-11-16)24(29)28-22(14-15-23(28)25(30)31)19-7-2-4-8-20(19)26/h2-13,22-23,27H,14-15H2,1H3,(H,30,31)/t22-,23+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a>1.00E+3n/an/an/an/a



Epics Therapeutics

US Patent


Assay Description
The assay was used to determine the activity of the compounds of the invention.The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM N...


US Patent US10781171 (2020)

More data for this
Ligand-Target Pair
Free fatty acid receptor 2


(Homo sapiens (Human))
BDBM403942
PNG
((2R,5R)-5-(2-chlorophenyl)-1-(2'-methoxy-[1,1'-bip...)
Show SMILES COc1ccccc1-c1ccc(cc1)C(=O)N1[C@H](CC[C@@H]1c1ccccc1Cl)C(O)=O
Show InChI InChI=1S/C25H22ClNO4/c1-31-23-9-5-3-6-18(23)16-10-12-17(13-11-16)24(28)27-21(14-15-22(27)25(29)30)19-7-2-4-8-20(19)26/h2-13,21-22H,14-15H2,1H3,(H,29,30)/t21-,22-/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a>1.00E+3n/an/an/an/a



Epics Therapeutics

US Patent


Assay Description
The assay was used to determine the activity of the compounds of the invention.The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM N...


US Patent US10781171 (2020)

More data for this
Ligand-Target Pair
Free fatty acid receptor 2


(Homo sapiens (Human))
BDBM403943
PNG
((2S,5R)-5-(2-chlorophenyl)-1-(1-phenyl-1H-benzo[d]...)
Show SMILES OC(=O)[C@@H]1CC[C@@H](N1C(=O)c1ccc2n(cnc2c1)-c1ccccc1)c1ccccc1Cl
Show InChI InChI=1S/C25H20ClN3O3/c26-19-9-5-4-8-18(19)21-12-13-23(25(31)32)29(21)24(30)16-10-11-22-20(14-16)27-15-28(22)17-6-2-1-3-7-17/h1-11,14-15,21,23H,12-13H2,(H,31,32)/t21-,23+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a>1.00E+3n/an/an/an/a



Epics Therapeutics

US Patent


Assay Description
The assay was used to determine the activity of the compounds of the invention.The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM N...


US Patent US10781171 (2020)

More data for this
Ligand-Target Pair
Free fatty acid receptor 2


(Homo sapiens (Human))
BDBM403945
PNG
((2S,5R)-1-(2-chloro-[1,1'-biphenyl]-4-carbonyl)-5-...)
Show SMILES OC(=O)[C@@H]1CC[C@@H](N1C(=O)c1ccc(c(Cl)c1)-c1ccccc1)c1ccccc1Cl
Show InChI InChI=1S/C24H19Cl2NO3/c25-19-9-5-4-8-18(19)21-12-13-22(24(29)30)27(21)23(28)16-10-11-17(20(26)14-16)15-6-2-1-3-7-15/h1-11,14,21-22H,12-13H2,(H,29,30)/t21-,22+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a<200n/an/an/an/a



Epics Therapeutics

US Patent


Assay Description
The assay was used to determine the activity of the compounds of the invention.The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM N...


US Patent US10781171 (2020)

More data for this
Ligand-Target Pair
Free fatty acid receptor 2


(Homo sapiens (Human))
BDBM403962
PNG
((2S,5R)-5-(2-chlorophenyl)-1-(3-methoxy-4-(pyrimid...)
Show SMILES COc1cc(ccc1-c1cncnc1)C(=O)N1[C@@H](CC[C@@H]1c1ccccc1Cl)C(O)=O
Show InChI InChI=1S/C23H20ClN3O4/c1-31-21-10-14(6-7-16(21)15-11-25-13-26-12-15)22(28)27-19(8-9-20(27)23(29)30)17-4-2-3-5-18(17)24/h2-7,10-13,19-20H,8-9H2,1H3,(H,29,30)/t19-,20+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a>1.00E+3n/an/an/an/a



Epics Therapeutics

US Patent


Assay Description
The assay was used to determine the activity of the compounds of the invention.The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM N...


US Patent US10781171 (2020)

More data for this
Ligand-Target Pair
Free fatty acid receptor 2


(Homo sapiens (Human))
BDBM403963
PNG
((2S,5R)-1-(2'-carbamimidoyl-[1,1'-biphenyl]-4-carb...)
Show SMILES NC(=N)c1ccccc1-c1ccc(cc1)C(=O)N1[C@@H](CC[C@@H]1c1ccccc1Cl)C(O)=O
Show InChI InChI=1S/C25H22ClN3O3/c26-20-8-4-3-7-19(20)21-13-14-22(25(31)32)29(21)24(30)16-11-9-15(10-12-16)17-5-1-2-6-18(17)23(27)28/h1-12,21-22H,13-14H2,(H3,27,28)(H,31,32)/t21-,22+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a>1.00E+3n/an/an/an/a



Epics Therapeutics

US Patent


Assay Description
The assay was used to determine the activity of the compounds of the invention.The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM N...


US Patent US10781171 (2020)

More data for this
Ligand-Target Pair
Free fatty acid receptor 2


(Homo sapiens (Human))
BDBM403967
PNG
((2S,5R)-5-(2-chlorophenyl)-1-(2'-(methoxymethyl)-[...)
Show SMILES COCc1ccccc1-c1ccc(cc1)C(=O)N1[C@@H](CC[C@@H]1c1ccccc1Cl)C(O)=O
Show InChI InChI=1S/C26H24ClNO4/c1-32-16-19-6-2-3-7-20(19)17-10-12-18(13-11-17)25(29)28-23(14-15-24(28)26(30)31)21-8-4-5-9-22(21)27/h2-13,23-24H,14-16H2,1H3,(H,30,31)/t23-,24+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a<200n/an/an/an/a



Epics Therapeutics

US Patent


Assay Description
The assay was used to determine the activity of the compounds of the invention.The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM N...


US Patent US10781171 (2020)

More data for this
Ligand-Target Pair
Free fatty acid receptor 2


(Homo sapiens (Human))
BDBM403987
PNG
((2S,5R)-1-(4-(2,4-dimethoxypyrimidin-5-yl)benzoyl)...)
Show SMILES COc1ncc(c(OC)n1)-c1ccc(cc1)C(=O)N1[C@@H](CC[C@@H]1c1ccccc1F)C(O)=O
Show InChI InChI=1S/C24H22FN3O5/c1-32-21-17(13-26-24(27-21)33-2)14-7-9-15(10-8-14)22(29)28-19(11-12-20(28)23(30)31)16-5-3-4-6-18(16)25/h3-10,13,19-20H,11-12H2,1-2H3,(H,30,31)/t19-,20+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a<200n/an/an/an/a



Epics Therapeutics

US Patent


Assay Description
The assay was used to determine the activity of the compounds of the invention.The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM N...


US Patent US10781171 (2020)

More data for this
Ligand-Target Pair
Free fatty acid receptor 2


(Homo sapiens (Human))
BDBM404040
PNG
((2S,5R)-5-cyclohexyl-1-(2'-methoxy-[1,1'-biphenyl]...)
Show SMILES COc1ccccc1-c1ccc(cc1)C(=O)N1[C@H](CC[C@H]1C(O)=O)C1CCCCC1
Show InChI InChI=1S/C25H29NO4/c1-30-23-10-6-5-9-20(23)17-11-13-19(14-12-17)24(27)26-21(15-16-22(26)25(28)29)18-7-3-2-4-8-18/h5-6,9-14,18,21-22H,2-4,7-8,15-16H2,1H3,(H,28,29)/t21-,22+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 600n/an/an/an/a



Epics Therapeutics

US Patent


Assay Description
The assay was used to determine the activity of the compounds of the invention.The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM N...


US Patent US10781171 (2020)

More data for this
Ligand-Target Pair
Free fatty acid receptor 2


(Homo sapiens (Human))
BDBM404066
PNG
((2R,5R)-5-(2-fluorophenyl)-1-(2'-methoxy-[1,1'-bip...)
Show SMILES COc1ccccc1-c1ccc(cc1)C(=O)N1[C@H](CC[C@@H]1c1ccccc1F)C(O)=O
Show InChI InChI=1S/C25H22FNO4/c1-31-23-9-5-3-6-18(23)16-10-12-17(13-11-16)24(28)27-21(14-15-22(27)25(29)30)19-7-2-4-8-20(19)26/h2-13,21-22H,14-15H2,1H3,(H,29,30)/t21-,22-/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a>1.00E+3n/an/an/an/a



Epics Therapeutics

US Patent


Assay Description
The assay was used to determine the activity of the compounds of the invention.The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM N...


US Patent US10781171 (2020)

More data for this
Ligand-Target Pair
Free fatty acid receptor 2


(Homo sapiens (Human))
BDBM404098
PNG
((2S,5R)-5-isobutyl-1-(2'-methoxy-[1,1'-biphenyl]-4...)
Show SMILES COc1ccccc1-c1ccc(cc1)C(=O)N1[C@@H](CC(C)C)CC[C@H]1C(O)=O
Show InChI InChI=1S/C23H27NO4/c1-15(2)14-18-12-13-20(23(26)27)24(18)22(25)17-10-8-16(9-11-17)19-6-4-5-7-21(19)28-3/h4-11,15,18,20H,12-14H2,1-3H3,(H,26,27)/t18-,20+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 600n/an/an/an/a



Epics Therapeutics

US Patent


Assay Description
The assay was used to determine the activity of the compounds of the invention.The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM N...


US Patent US10781171 (2020)

More data for this
Ligand-Target Pair
Free fatty acid receptor 2


(Homo sapiens (Human))
BDBM404099
PNG
((2S,5R)-5-isopropyl-1-(2'-methoxy-[1,1'-biphenyl]-...)
Show SMILES COc1ccccc1-c1ccc(cc1)C(=O)N1[C@H](CC[C@H]1C(O)=O)C(C)C
Show InChI InChI=1S/C22H25NO4/c1-14(2)18-12-13-19(22(25)26)23(18)21(24)16-10-8-15(9-11-16)17-6-4-5-7-20(17)27-3/h4-11,14,18-19H,12-13H2,1-3H3,(H,25,26)/t18-,19+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a>1.00E+3n/an/an/an/a



Epics Therapeutics

US Patent


Assay Description
The assay was used to determine the activity of the compounds of the invention.The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM N...


US Patent US10781171 (2020)

More data for this
Ligand-Target Pair
Free fatty acid receptor 2


(Homo sapiens (Human))
BDBM404121
PNG
((2S,4S,5R)-5-(2-chlorophenyl)-4-cyano-1-(2'-methox...)
Show SMILES COc1ccccc1-c1ccc(cc1)C(=O)N1[C@@H](C[C@](C)(C#N)[C@@H]1c1ccccc1Cl)C(O)=O
Show InChI InChI=1S/C27H23ClN2O4/c1-27(16-29)15-22(26(32)33)30(24(27)20-8-3-5-9-21(20)28)25(31)18-13-11-17(12-14-18)19-7-4-6-10-23(19)34-2/h3-14,22,24H,15H2,1-2H3,(H,32,33)/t22-,24-,27+/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a>1.00E+3n/an/an/an/a



Epics Therapeutics

US Patent


Assay Description
The assay was used to determine the activity of the compounds of the invention.The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM N...


US Patent US10781171 (2020)

More data for this
Ligand-Target Pair
Free fatty acid receptor 2


(Homo sapiens (Human))
BDBM404137
PNG
((2S,5R)-1-(2,2'-dimethoxy-[1,1'-biphenyl]-4-carbon...)
Show SMILES COc1ccccc1-c1ccc(cc1OC)C(=O)N1[C@@H](CC[C@@H]1c1ccccc1F)C(O)=O
Show InChI InChI=1S/C26H24FNO5/c1-32-23-10-6-4-7-17(23)18-12-11-16(15-24(18)33-2)25(29)28-21(13-14-22(28)26(30)31)19-8-3-5-9-20(19)27/h3-12,15,21-22H,13-14H2,1-2H3,(H,30,31)/t21-,22+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a<200n/an/an/an/a



Epics Therapeutics

US Patent


Assay Description
The assay was used to determine the activity of the compounds of the invention.The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM N...


US Patent US10781171 (2020)

More data for this
Ligand-Target Pair
Free fatty acid receptor 2


(Homo sapiens (Human))
BDBM404171
PNG
((2S,5R)-5-(2-bromophenyl)-1-(2'-methoxy-[1,1'-biph...)
Show SMILES COc1ccccc1-c1ccc(cc1)C(=O)N1[C@@H](CC[C@@H]1c1ccccc1Br)C(O)=O
Show InChI InChI=1S/C25H22BrNO4/c1-31-23-9-5-3-6-18(23)16-10-12-17(13-11-16)24(28)27-21(14-15-22(27)25(29)30)19-7-2-4-8-20(19)26/h2-13,21-22H,14-15H2,1H3,(H,29,30)/t21-,22+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a<200n/an/an/an/a



Epics Therapeutics

US Patent


Assay Description
The assay was used to determine the activity of the compounds of the invention.The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM N...


US Patent US10781171 (2020)

More data for this
Ligand-Target Pair
Free fatty acid receptor 2


(Homo sapiens (Human))
BDBM404173
PNG
((2S,5R)-5-(2-chlorophenyl)-1-(3'-cyano-[1,1'-biphe...)
Show SMILES OC(=O)[C@@H]1CC[C@@H](N1C(=O)c1ccc(cc1)-c1cccc(c1)C#N)c1ccccc1Cl
Show InChI InChI=1S/C25H19ClN2O3/c26-21-7-2-1-6-20(21)22-12-13-23(25(30)31)28(22)24(29)18-10-8-17(9-11-18)19-5-3-4-16(14-19)15-27/h1-11,14,22-23H,12-13H2,(H,30,31)/t22-,23+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 600n/an/an/an/a



Epics Therapeutics

US Patent


Assay Description
The assay was used to determine the activity of the compounds of the invention.The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM N...


US Patent US10781171 (2020)

More data for this
Ligand-Target Pair
Free fatty acid receptor 2


(Homo sapiens (Human))
BDBM404190
PNG
((2S,5R)-5-(2,4-difluorophenyl)-1-(4-(2,6-dimethoxy...)
Show SMILES COc1ccc(c(OC)n1)-c1ccc(cc1)C(=O)N1[C@@H](CC[C@@H]1c1ccc(F)cc1F)C(O)=O
Show InChI InChI=1S/C25H22F2N2O5/c1-33-22-12-9-17(23(28-22)34-2)14-3-5-15(6-4-14)24(30)29-20(10-11-21(29)25(31)32)18-8-7-16(26)13-19(18)27/h3-9,12-13,20-21H,10-11H2,1-2H3,(H,31,32)/t20-,21+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a<200n/an/an/an/a



Epics Therapeutics

US Patent


Assay Description
The assay was used to determine the activity of the compounds of the invention.The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM N...


US Patent US10781171 (2020)

More data for this
Ligand-Target Pair
Free fatty acid receptor 2


(Homo sapiens (Human))
BDBM404193
PNG
((2S,5R)-5-(2-chlorophenyl)-1-(2',3,6'-trimethoxy-[...)
Show SMILES COc1ccc(c(OC)n1)-c1ncc(cc1OC)C(=O)N1[C@@H](CC[C@@H]1c1ccccc1Cl)C(O)=O
Show InChI InChI=1S/C25H24ClN3O6/c1-33-20-12-14(13-27-22(20)16-8-11-21(34-2)28-23(16)35-3)24(30)29-18(9-10-19(29)25(31)32)15-6-4-5-7-17(15)26/h4-8,11-13,18-19H,9-10H2,1-3H3,(H,31,32)/t18-,19+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 600n/an/an/an/a



Epics Therapeutics

US Patent


Assay Description
The assay was used to determine the activity of the compounds of the invention.The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM N...


US Patent US10781171 (2020)

More data for this
Ligand-Target Pair
Free fatty acid receptor 2


(Homo sapiens (Human))
BDBM404215
PNG
((2S,5R)-5-(2-chlorophenyl)-1-(2'-cyano-2-fluoro-[1...)
Show SMILES OC(=O)[C@@H]1CC[C@@H](N1C(=O)c1ccc(c(F)c1)-c1ccccc1C#N)c1ccccc1Cl
Show InChI InChI=1S/C25H18ClFN2O3/c26-20-8-4-3-7-19(20)22-11-12-23(25(31)32)29(22)24(30)15-9-10-18(21(27)13-15)17-6-2-1-5-16(17)14-28/h1-10,13,22-23H,11-12H2,(H,31,32)/t22-,23+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a<200n/an/an/an/a



Epics Therapeutics

US Patent


Assay Description
The assay was used to determine the activity of the compounds of the invention.The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM N...


US Patent US10781171 (2020)

More data for this
Ligand-Target Pair
Free fatty acid receptor 2


(Homo sapiens (Human))
BDBM404217
PNG
((2S,5R)-5-(2-chlorophenyl)-1-(1-(2-cyano-4-methoxy...)
Show SMILES COc1ccc(N2CCC(CC2)C(=O)N2[C@@H](CC[C@@H]2c2ccccc2Cl)C(O)=O)c(c1)C#N
Show InChI InChI=1S/C25H26ClN3O4/c1-33-18-6-7-21(17(14-18)15-27)28-12-10-16(11-13-28)24(30)29-22(8-9-23(29)25(31)32)19-4-2-3-5-20(19)26/h2-7,14,16,22-23H,8-13H2,1H3,(H,31,32)/t22-,23+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a>1.00E+3n/an/an/an/a



Epics Therapeutics

US Patent


Assay Description
The assay was used to determine the activity of the compounds of the invention.The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM N...


US Patent US10781171 (2020)

More data for this
Ligand-Target Pair
Free fatty acid receptor 2


(Homo sapiens (Human))
BDBM404220
PNG
((2S,5R)-5-(2-chlorophenyl)-1-(1-(2-(methylsulfonam...)
Show SMILES CS(=O)(=O)Nc1cc(ccc1N1CCC(CC1)C(=O)N1[C@@H](CC[C@@H]1c1ccccc1Cl)C(O)=O)C(F)(F)F
Show InChI InChI=1S/C25H27ClF3N3O5S/c1-38(36,37)30-19-14-16(25(27,28)29)6-7-21(19)31-12-10-15(11-13-31)23(33)32-20(8-9-22(32)24(34)35)17-4-2-3-5-18(17)26/h2-7,14-15,20,22,30H,8-13H2,1H3,(H,34,35)/t20-,22+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a>1.00E+3n/an/an/an/a



Epics Therapeutics

US Patent


Assay Description
The assay was used to determine the activity of the compounds of the invention.The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM N...


US Patent US10781171 (2020)

More data for this
Ligand-Target Pair
Free fatty acid receptor 2


(Homo sapiens (Human))
BDBM404228
PNG
((2S,5R)-5-(2,3-difluorophenyl)-1-(2'-methoxy-[1,1'...)
Show SMILES COc1ccccc1-c1ccc(cc1)C(=O)N1[C@@H](CC[C@@H]1c1cccc(F)c1F)C(O)=O
Show InChI InChI=1S/C25H21F2NO4/c1-32-22-8-3-2-5-17(22)15-9-11-16(12-10-15)24(29)28-20(13-14-21(28)25(30)31)18-6-4-7-19(26)23(18)27/h2-12,20-21H,13-14H2,1H3,(H,30,31)/t20-,21+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a<200n/an/an/an/a



Epics Therapeutics

US Patent


Assay Description
The assay was used to determine the activity of the compounds of the invention.The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM N...


US Patent US10781171 (2020)

More data for this
Ligand-Target Pair
Free fatty acid receptor 2


(Homo sapiens (Human))
BDBM404246
PNG
((2S,5R)-1-(3'-cyano-4'-fluoro-[1,1'-biphenyl]-4-ca...)
Show SMILES OC(=O)[C@@H]1CC[C@@H](N1C(=O)c1ccc(cc1)-c1ccc(F)c(c1)C#N)c1ccccc1F
Show InChI InChI=1S/C25H18F2N2O3/c26-20-10-9-17(13-18(20)14-28)15-5-7-16(8-6-15)24(30)29-22(11-12-23(29)25(31)32)19-3-1-2-4-21(19)27/h1-10,13,22-23H,11-12H2,(H,31,32)/t22-,23+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a>1.00E+3n/an/an/an/a



Epics Therapeutics

US Patent


Assay Description
The assay was used to determine the activity of the compounds of the invention.The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM N...


US Patent US10781171 (2020)

More data for this
Ligand-Target Pair
Free fatty acid receptor 2


(Homo sapiens (Human))
BDBM404253
PNG
((2S,5R)-5-(2,3-difluorophenyl)-1-(4-(2,4-dimethoxy...)
Show SMILES COc1ncc(c(OC)n1)-c1ccc(cc1)C(=O)N1[C@@H](CC[C@@H]1c1cccc(F)c1F)C(O)=O
Show InChI InChI=1S/C24H21F2N3O5/c1-33-21-16(12-27-24(28-21)34-2)13-6-8-14(9-7-13)22(30)29-18(10-11-19(29)23(31)32)15-4-3-5-17(25)20(15)26/h3-9,12,18-19H,10-11H2,1-2H3,(H,31,32)/t18-,19+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a<200n/an/an/an/a



Epics Therapeutics

US Patent


Assay Description
The assay was used to determine the activity of the compounds of the invention.The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM N...


US Patent US10781171 (2020)

More data for this
Ligand-Target Pair
Free fatty acid receptor 2


(Homo sapiens (Human))
BDBM403786
PNG
((2S,5R)-5-(2-chlorophenyl)-1-(3-methoxy-5-phenetho...)
Show SMILES COc1cc(OCCc2ccccc2)cc(c1)C(=O)N1[C@@H](CC[C@@H]1c1ccccc1Cl)C(O)=O
Show InChI InChI=1S/C27H26ClNO5/c1-33-20-15-19(16-21(17-20)34-14-13-18-7-3-2-4-8-18)26(30)29-24(11-12-25(29)27(31)32)22-9-5-6-10-23(22)28/h2-10,15-17,24-25H,11-14H2,1H3,(H,31,32)/t24-,25+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a<200n/an/an/an/a



Epics Therapeutics

US Patent


Assay Description
The assay was used to determine the activity of the compounds of the invention.The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM N...


US Patent US10781171 (2020)

More data for this
Ligand-Target Pair
Free fatty acid receptor 2


(Homo sapiens (Human))
BDBM403802
PNG
((2S)-1-([1,1'-biphenyl]-4-carbonyl)-4-benzyl-5-phe...)
Show SMILES OC(=O)[C@@H]1CC(Cc2ccccc2)C(N1C(=O)c1ccc(cc1)-c1ccccc1)c1ccccc1
Show InChI InChI=1S/C31H27NO3/c33-30(26-18-16-24(17-19-26)23-12-6-2-7-13-23)32-28(31(34)35)21-27(20-22-10-4-1-5-11-22)29(32)25-14-8-3-9-15-25/h1-19,27-29H,20-21H2,(H,34,35)/t27?,28-,29?/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a>1.00E+3n/an/an/an/a



Epics Therapeutics

US Patent


Assay Description
The assay was used to determine the activity of the compounds of the invention.The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM N...


US Patent US10781171 (2020)

More data for this
Ligand-Target Pair
Free fatty acid receptor 2


(Homo sapiens (Human))
BDBM403809
PNG
((2S,5R)-5-(2-chlorophenyl)-1-(1-(4-methoxyphenyl)-...)
Show SMILES COc1ccc(cc1)-n1nc(cc1-c1ccccc1)C(=O)N1[C@@H](CC[C@@H]1c1ccccc1Cl)C(O)=O
Show InChI InChI=1S/C28H24ClN3O4/c1-36-20-13-11-19(12-14-20)32-26(18-7-3-2-4-8-18)17-23(30-32)27(33)31-24(15-16-25(31)28(34)35)21-9-5-6-10-22(21)29/h2-14,17,24-25H,15-16H2,1H3,(H,34,35)/t24-,25+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a>1.00E+3n/an/an/an/a



Epics Therapeutics

US Patent


Assay Description
The assay was used to determine the activity of the compounds of the invention.The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM N...


US Patent US10781171 (2020)

More data for this
Ligand-Target Pair
Free fatty acid receptor 2


(Homo sapiens (Human))
BDBM403810
PNG
((2S,5R)-5-(2-chlorophenyl)-1-(4-isopropoxybenzoyl)...)
Show SMILES CC(C)Oc1ccc(cc1)C(=O)N1[C@@H](CC[C@@H]1c1ccccc1Cl)C(O)=O
Show InChI InChI=1S/C21H22ClNO4/c1-13(2)27-15-9-7-14(8-10-15)20(24)23-18(11-12-19(23)21(25)26)16-5-3-4-6-17(16)22/h3-10,13,18-19H,11-12H2,1-2H3,(H,25,26)/t18-,19+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a>1.00E+3n/an/an/an/a



Epics Therapeutics

US Patent


Assay Description
The assay was used to determine the activity of the compounds of the invention.The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM N...


US Patent US10781171 (2020)

More data for this
Ligand-Target Pair
Free fatty acid receptor 2


(Homo sapiens (Human))
BDBM403817
PNG
((2S,5R)-5-(2-chlorophenyl)-1-(4-(5-cyclopropyl-1,2...)
Show SMILES OC(=O)[C@@H]1CC[C@@H](N1C(=O)c1ccc(cc1)-c1noc(n1)C1CC1)c1ccccc1Cl
Show InChI InChI=1S/C23H20ClN3O4/c24-17-4-2-1-3-16(17)18-11-12-19(23(29)30)27(18)22(28)15-9-5-13(6-10-15)20-25-21(31-26-20)14-7-8-14/h1-6,9-10,14,18-19H,7-8,11-12H2,(H,29,30)/t18-,19+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a>1.00E+3n/an/an/an/a



Epics Therapeutics

US Patent


Assay Description
The assay was used to determine the activity of the compounds of the invention.The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM N...


US Patent US10781171 (2020)

More data for this
Ligand-Target Pair
Displayed 1 to 50 (of 288 total )  |  Next  |  Last  >>
* indicates data uncertainty>20%